IMVT vs. IRWD

In the year-to-date period, IMVT achieves a -7.63% return, which is significantly higher than IRWD's -17.61% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Immunovant, Inc. (IMVT) and Ironwood Pharmaceuticals, Inc. (IRWD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current IMVT Sharpe Ratio is -1.10, which is comparable to the IRWD Sharpe Ratio of -0.86. The chart below compares the historical Sharpe Ratios of IMVT and IRWD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither IMVT nor IRWD has paid dividends to shareholders.

The maximum IMVT drawdown since its inception was -93.59%, which is greater than IRWD's maximum drawdown of -81.06%. Use the drawdown chart below to compare losses from any high point for IMVT and IRWD. For additional features, visit the drawdowns tool.

The current volatility for Immunovant, Inc. (IMVT) is 13.36%, while Ironwood Pharmaceuticals, Inc. (IRWD) has a volatility of 25.93%. This indicates that IMVT experiences smaller price fluctuations and is considered to be less risky than IRWD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Immunovant, Inc. and Ironwood Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.